Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data

被引:385
作者
Friedrich, Jan O. [1 ]
Adhikari, Neill K. J.
Beyene, Joseph
机构
[1] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada
[2] St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada
[3] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada
[5] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[6] Hosp Sick Children, Res Inst, Toronto, ON M5G 1E2, Canada
关键词
D O I
10.1186/1471-2288-7-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Meta-analysis handles randomized trials with no outcome events in both treatment and control arms inconsistently, including them when risk difference (RD) is the effect measure but excluding them when relative risk (RR) or odds ratio (OR) are used. This study examined the influence of such trials on pooled treatment effects. Methods: Analysis with and without zero total event trials of three illustrative published meta-analyses with a range of proportions of zero total event trials, treatment effects, and heterogeneity using inverse variance weighting and random effects that incorporates between-study heterogeneity. Results: Including zero total event trials in meta-analyses moves the pooled estimate of treatment effect closer to nil, decreases its confidence interval and decreases between-study heterogeneity. For RR and OR, inclusion of such trials causes small changes, even when they comprise the large majority of included trials. For RD, the changes are more substantial, and in extreme cases can eliminate a statistically significant effect estimate. Conclusion: To include all relevant data regardless of effect measure chosen, reviewers should also include zero total event trials when calculating pooled estimates using OR and RR.
引用
收藏
页数:6
相关论文
共 17 条
[1]  
[Anonymous], REVMAN 4 2 US GUID
[2]   Antifungal prophylaxis for severely neutropenic chemotherapy recipients -: A meta-analysis of randomized-controlled clinical trials [J].
Bow, EJ ;
Laverdiére, M ;
Lussier, N ;
Rotstein, C ;
Cheang, MS ;
Ioannou, S .
CANCER, 2002, 94 (12) :3230-3246
[3]   Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events [J].
Bradburn, Michael J. ;
Deeks, Jonathan J. ;
Berlin, Jesse A. ;
Localio, A. Russell .
STATISTICS IN MEDICINE, 2007, 26 (01) :53-77
[4]  
*COCHR COLL, 2005, COCHR HDB SYST REV I
[5]   STRESS-ULCER PROPHYLAXIS IN THE CRITICALLY ILL - A METAANALYSIS [J].
COOK, DJ ;
WITT, LG ;
COOK, RJ ;
GUYATT, GH .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (05) :519-527
[6]  
COX DR, 1970, BIOMETRIKA, V57, P217, DOI 10.2307/2334957
[7]  
Del Mar C., 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000023.PUB2
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Meta-analysis: Principles and procedures [J].
Egger, M ;
Smith, GD ;
Phillips, AN .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7121) :1533-1537
[10]   Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death [J].
Friedrich, JO ;
Adhikari, N ;
Herridge, MS ;
Beyene, J .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (07) :510-524